| 1 | 212 441 40 01 | | | | | | | 2 | 0.79% |
| 2 | 2 2019june 8 2022 | | | | | | | 2 | 0.79% |
| 3 | 90 212 441 40 | | | | | | | 2 | 0.79% |
| 4 | november 2 2019june 8 | | | | | | | 2 | 0.79% |
| 5 | on november 2 2019june | | | | | | | 2 | 0.79% |
| 6 | rootyq445osmposted on november 2 | | | | | | | 2 | 0.79% |
| 7 | loading asfarma telephone90 212 | | | | | | | 1 | 0.39% |
| 8 | system and sex hormones | | | | | | | 1 | 0.39% |
| 9 | immune system view details | | | | | | | 1 | 0.39% |
| 10 | dermatologicals view details genitourinary | | | | | | | 1 | 0.39% |
| 11 | view details genitourinary system | | | | | | | 1 | 0.39% |
| 12 | details genitourinary system and | | | | | | | 1 | 0.39% |
| 13 | genitourinary system and sex | | | | | | | 1 | 0.39% |
| 14 | view details antineoplastic and | | | | | | | 1 | 0.39% |
| 15 | view details immune system | | | | | | | 1 | 0.39% |
| 16 | details antineoplastic and immunomodulating | | | | | | | 1 | 0.39% |
| 17 | antineoplastic and immunomodulating agents | | | | | | | 1 | 0.39% |
| 18 | and immunomodulating agents view | | | | | | | 1 | 0.39% |
| 19 | immunomodulating agents view details | | | | | | | 1 | 0.39% |
| 20 | blood and blood forming | | | | | | | 1 | 0.39% |
| 21 | and blood forming organs | | | | | | | 1 | 0.39% |
| 22 | blood forming organs view | | | | | | | 1 | 0.39% |
| 23 | forming organs view details | | | | | | | 1 | 0.39% |
| 24 | organs view details cardiovascular | | | | | | | 1 | 0.39% |
| 25 | view details cardiovascular system | | | | | | | 1 | 0.39% |
| 26 | details immune system view | | | | | | | 1 | 0.39% |
| 27 | musculoskeletal system view details | | | | | | | 1 | 0.39% |
| 28 | system view details immune | | | | | | | 1 | 0.39% |
| 29 | details antiinfectives view details | | | | | | | 1 | 0.39% |
| 30 | 12 suppliers 450 professional | | | | | | | 1 | 0.39% |
| 31 | suppliers 450 professional staff | | | | | | | 1 | 0.39% |
| 32 | 11 countries our partners | | | | | | | 1 | 0.39% |
| 33 | countries our partners our | | | | | | | 1 | 0.39% |
| 34 | our partners our portfolio | | | | | | | 1 | 0.39% |
| 35 | partners our portfolio explore | | | | | | | 1 | 0.39% |
| 36 | our portfolio explore our | | | | | | | 1 | 0.39% |
| 37 | portfolio explore our products | | | | | | | 1 | 0.39% |
| 38 | explore our products view | | | | | | | 1 | 0.39% |
| 39 | antiinfectives view details alimentary | | | | | | | 1 | 0.39% |
| 40 | details dermatological collagen combinations | | | | | | | 1 | 0.39% |